Latest Insmed News & Updates

See the latest news and media coverage for Insmed. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Insmed

Biopharmaceutical company developing therapies for serious diseases

insmed.com
Headquarters
Bridgewater Township, United States
Company type
Public company
Number of employees
1,700–5,000

Last updated

Latest news about Insmed

In short: Insmed achieved regulatory approvals for Brinsupri and reported robust revenue growth, despite facing clinical setbacks in its brensocatib program.

Company announcements

Insmed

Insmed reports Q1 2026 financial results

Total revenues reach $306M with BRINSUPRI at $207.9M and ARIKAYCE at $98.1M. Reiterates 2026 guidance. ENCORE study meets endpoints; PALM-PAH initiated.

Insmed

Insmed announces positive topline results from Phase 3b ENCORE study

The study met primary and secondary endpoints, showing improvements in respiratory symptoms and culture conversion rates for ARIKAYCE in MAC lung disease patients. Insmed plans sNDA filing in 2026.

Unlock all announcements with a

Media coverage

Yahoo Finance

ATS 2026: Insmed shines in bronchiectasis with spotlight on Brinsupri

As the first-to-market DPP-1 inhibitor, Brinsupri is on course to become the standard of care in bronchiectasis treatment.

Unlock all articles with a

Never miss news about Insmed

Track Insmed and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Insmed competitors & trending companies

Browse news for competitors to Insmed and other trending companies.